Subscribe to RSS
DOI: 10.1055/a-2780-8854
Intra- and Inter-individual Variability of Platelet-rich Plasma Volume and Cellular Composition, and Associated Clinical Outcomes in Dogs Treated for Elbow Dysplasia
Authors
Abstract
Platelet-rich plasma (PRP) is a biological product commonly used in veterinary orthopaedics. There is a lack of descriptive information of the final product used in clinical studies.
Objective
The objectives were to describe and analyze the intra-individual variability of the quantity and cellular composition of the autologous conditioned plasma (ACP) obtained at various time points in each patient in a group of dogs suffering from elbow dysplasia, and to describe the outcome from an owner's perception.
Study Design
Dogs diagnosed with elbow dysplasia treated with three ACP injections 1 week apart were included. A complete blood count on whole blood and ACP was documented in at least two infiltrations. Volume of ACP and degree of platelet increased concentration factor, leukocyte and red blood cell decreased reduction factor were evaluated at each time point. Intra-individual variability of ACP characteristics, mean ACP volume collected and injected, and number of injected platelets were analyzed. Canine brief pain inventory (CBPI) scores were recorded.
Results
In this study 23 dogs were included. No difference was observed in intra-individual ACP volume collected, leukocyte reduction factor and red blood cell reduction factor, or number of platelets injected at various time points, while a significant difference was observed in intra-individual platelets concentration factor. The CBPI scores decreased between pre- and post-injection scores in the majority of the patients.
Conclusion
Regarding ACP, platelets concentration factor is variable in the same patient at various time points while the volume collected and the purity are stable.
Contributors' Statement
J.B.C. contributed to conceptualization, data curation, methodology, writing—original draft, writing—review and editing; J.M. contributed to conceptualization, supervision; J.A.F. contributed to conceptualization, formal analysis, methodology.
Publication History
Received: 15 May 2025
Accepted: 02 January 2026
Article published online:
19 January 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Carr BJ. Platelet-rich plasma as an orthobiologic: clinically relevant considerations. Vet Clin North Am Small Anim Pract 2022; 52 (04) 977-995
- 2 Miller AV, Carney PC, Markmann A, Frye CW. Retrospective analysis describes safety of therapeutic joint injections in dogs. J Am Vet Med Assoc 2023; 261 (03) 397-402
- 3 Carr BJ, Miller AV, Colbath AC, Peralta S, Frye CW. Literature review details and supports the application of platelet-rich plasma products in canine medicine, particularly as an orthobiologic agent for osteoarthritis. J Am Vet Med Assoc 2024; 262 (S1): S8-S15
- 4 Stief M, Gottschalk J, Ionita JC, Einspanier A, Oechtering G, Böttcher P. Concentration of platelets and growth factors in canine autologous conditioned plasma. Vet Comp Orthop Traumatol 2011; 24 (02) 122-125
- 5 Bozynski CC, Stannard JP, Smith P. et al. Acute management of anterior cruciate ligament injuries using novel canine models. J Knee Surg 2016; 29 (07) 594-603
- 6 Cook JL, Smith PA, Bozynski CC. et al. Multiple injections of leukoreduced platelet rich plasma reduce pain and functional impairment in a canine model of ACL and meniscal deficiency. J Orthop Res 2016; 34 (04) 607-615
- 7 Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent 2001; 10 (04) 225-228
- 8 Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27 (03) 158-167
- 9 DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy 2012; 28 (07) 998-1009
- 10 Hsu WK, Mishra A, Rodeo SR. et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg 2013; 21 (12) 739-748
- 11 Magalon J, Chateau AL, Bertrand B. et al. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med 2016; 2 (01) e000060
- 12 Mazzocca AD, McCarthy MB, Chowaniec DM. et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012; 94 (04) 308-316
- 13 Franklin SP, Garner BC, Cook JL. Characteristics of canine platelet-rich plasma prepared with five commercially available systems. Am J Vet Res 2015; 76 (09) 822-827
- 14 Goodale MB, Phelps HA, Barnhard JA, Shoben AB, Brunke MW. Lower centrifugation speed and time are positively associated with platelet concentration in a canine autologous conditioned plasma system. J Am Vet Med Assoc 2023; 261 (11) 1-6
- 15 Jones RL, Frederick SW, Cross AR. The effect of two platelet-rich plasma aspiration techniques on plasma cellular concentrations using a double syringe gravitational centrifugation system. Vet Surg 2024; 53 (05) 936-941
- 16 Ludwig HC, Birdwhistell KE, Brainard BM, Franklin SP. Use of a cyclooxygenase-2 inhibitor does not inhibit platelet activation or growth factor release from platelet-rich plasma. Am J Sports Med 2017; 45 (14) 3351-3357
- 17 Fahie MA, Ortolano GA, Guercio V. et al. A randomized controlled trial of the efficacy of autologous platelet therapy for the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 2013; 243 (09) 1291-1297
- 18 Alves JCA, Santos AMMPD, Jorge PIF, Lavrador CFTVB, Carreira LMA. Management of osteoarthritis using 1 intra-articular platelet concentrate administration in a canine osteoarthritis model. Am J Sports Med 2021; 49 (03) 599-608
- 19 Alves JC, Santos A, Jorge P. Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis. BMC Vet Res 2021; 17 (01) 207
- 20 Frye CW, Enders A, Brooks MB, Struble AM, Wakshlag JJ. Assessment of canine autologous platelet-rich plasma produced with a commercial centrifugation and platelet recovery kit. Vet Comp Orthop Traumatol 2016; 29 (01) 14-19
- 21 Franklin SP, Birdwhistell KE. Assessment of canine Autologous Conditioned PlasmaTM cellular and transforming growth factor-β1 content. Front Vet Sci 2018; 5: 105
- 22 Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am 2017; 99 (10) 809-819
- 23 Hurley ET, Sherman SL, Stokes DJ. et al; Members of the Biologics Association. Experts achieve consensus on a majority of statements regarding platelet-rich plasma treatments for treatment of musculoskeletal pathology. Arthroscopy 2024; 40 (02) 470-477.e1
- 24 Corsini A, Perticarini L, Palermi S, Bettinsoli P, Marchini A. Re-evaluating platelet-rich plasma dosing strategies in sports medicine: the role of the “10 billion platelet dose” in optimizing therapeutic outcomes—a narrative review. J Clin Med 2025; 14 (08) 2714
- 25 Nakagawa HF, Kim J, Rinaldi J. et al. Systematic review of randomized controlled trials evaluating the use of platelet-rich plasma for knee osteoarthritis: adherence to minimum information for studies evaluating biologics in orthopaedics. Am J Sports Med 2025; 53 (05) 1241-1253
- 26 Chahla J, Cinque ME, Piuzzi NS. et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017; 99 (20) 1769-1779
- 27 Matos Cruz AM, Mason DR. Owner assessed outcomes following elbow arthroscopy with or without platelet rich plasma for fragmented medial coronoid process. Front Vet Sci 2022; 9: 938706
- 28 Radke H, Joeris A, Chen M. Evidence-based evaluation of owner-reported outcome measures for canine orthopedic care—a COSMIN evaluation of 6 instruments. Vet Surg 2022; 51 (02) 244-253
- 29 Fitzpatrick N, Smith TJ, Evans RB, Yeadon R. Radiographic and arthroscopic findings in the elbow joints of 263 dogs with medial coronoid disease. Vet Surg 2009; 38 (02) 213-223
